I listened to the interview as well…great take away..In basic point form.
As previously mentioned they are seeing results in 3 of the 4 arms of goblet trial.
Onc is in consultation with FDA & pharma to find quickest way possible to get Pancreatic cancer approval ( sub text, with a pharma partner).
intersting , & first time in many years the point has been discussed.
Matt was very clear. " with the right market cap, we would welcome a large pharma buyout"
" so they could continue research & move Pelareorep to as broad a coverage as possible"
note, all of my quotes are from memory & as such paraphrase.
none- the- less.
And most importantly June was mentioned a few times as the " big reveal" of the Bracelet data & potential deal with Pfizer.
The Pancreatic cancer results are " now into 9 months of survival"...amazing!
He did not discuss details, other than as above. " as quick as possible"